================================================================================
ğŸ¤– ADC RESISTANCE MODEL TRAINING PIPELINE
================================================================================
Start time: 2025-10-18 03:13:52

âœ… Loaded 2020 labeled patients
   Studies: ['brca_tcga_pan_can_atlas_2018' 'brca_metabric']

================================================================================
TRAINING: ADC Resistance
================================================================================
âœ… Prepared 11 features for 2020 patients

ğŸ“Š Label distribution for adc_resistance_risk:
   Positive (HIGH_RISK): 11 (0.5%)
   Negative: 2009 (99.5%)

ğŸ“Š Data split:
   Train: 1616 samples (9 positive)
   Test:  404 samples (2 positive)

ğŸ”§ Training Logistic Regression...
   âœ… AUROC: 1.000
   âœ… AUPRC: 1.000

ğŸ”„ 5-Fold Cross-Validation (logistic)...
   âœ… AUROC: 1.000 Â± 0.000
   Fold scores: ['1.000', '1.000', '1.000', '1.000', '1.000']
   ğŸ“Š Saved ROC curve: /Users/fahadkiani/Desktop/development/crispr-assistant-main/oncology-coPilot/oncology-backend-minimal/data/yale_tdzd_project/results/roc_curve_adc_resistance.png

ğŸ’¾ Saved models: /Users/fahadkiani/Desktop/development/crispr-assistant-main/oncology-coPilot/oncology-backend-minimal/data/yale_tdzd_project/models/adc_resistance_models.pkl
ğŸ’¾ Saved metrics: /Users/fahadkiani/Desktop/development/crispr-assistant-main/oncology-coPilot/oncology-backend-minimal/data/yale_tdzd_project/results/adc_resistance_metrics.json

================================================================================
TRAINING: SG Cross-Resistance
================================================================================
âœ… Prepared 11 features for 2020 patients

ğŸ“Š Label distribution for sg_cross_resistance_risk:
   Positive (HIGH_RISK): 0 (0.0%)
   Negative: 2020 (100.0%)
âš ï¸  Too few positive samples (0), skipping SG Cross-Resistance

================================================================================
TRAINING: Endocrine Sensitivity
================================================================================
âœ… Prepared 11 features for 2020 patients

ğŸ“Š Label distribution for endocrine_sensitivity:
   Positive (HIGH_RISK): 0 (0.0%)
   Negative: 2020 (100.0%)
âš ï¸  Too few positive samples (0), skipping Endocrine Sensitivity

================================================================================
TRAINING: Eribulin Sensitivity
================================================================================
âœ… Prepared 11 features for 2020 patients

ğŸ“Š Label distribution for eribulin_sensitivity:
   Positive (HIGH_RISK): 0 (0.0%)
   Negative: 2020 (100.0%)
âš ï¸  Too few positive samples (0), skipping Eribulin Sensitivity

================================================================================
ğŸ“Š SUMMARY REPORT
================================================================================

       Therapy Logistic AUROC   Logistic CV  N Samples  N Positive
ADC Resistance          1.000 1.000 Â± 0.000       2020          11

ğŸ’¾ Saved summary: /Users/fahadkiani/Desktop/development/crispr-assistant-main/oncology-coPilot/oncology-backend-minimal/data/yale_tdzd_project/results/model_performance_summary.csv

================================================================================
ğŸ¯ TARGET CHECK (AUROC â‰¥ 0.70)
================================================================================

ADC Resistance: 1.000 âœ… PASS

================================================================================
âœ… TRAINING COMPLETE
================================================================================
End time: 2025-10-18 03:13:53

Next step: Validate models on external cohort (Yale data)
